Ferran Sanz is chemical engineer by the Institut Quimic de Sarrià (Barcelona) and BSc and PhD by the Universitat Autònoma de Barcelona. He is Professor of Biostatistics and Biomedical Informatics at Pompeu Fabra University (UPF), scientific staff of the Hospital del Mar Medical Research Institute (IMIM) and Director of the IMIM-UPF Research Programme on Biomedical Informatics (GRIB). He is also visiting professor at Naples, Düsseldorf and Vienna Universities.
Author of more than 130 articles in ISI-indexed journals. Mentor of 18 PhD thesis. Coordinator of nine EU-funded initiatives and a STOA report for the European Parliament. Currently, coordinator of an H2020 project on the translational and clinical application of Bioinformatics (MedBioinformatics) and academic coordinator of an IMI (Innovative Medicines Initiative) project on the in silico prediction of drug toxicity (eTOX). Partner in other ongoing EU-funded projects (OpenPHACTS, EMIF and iPiE). Academic Coordinator of the Spanish Technology Platform on Innovative Medicines (PTEMI). Coordinator of the Biomedical Informatics Node of the Spanish Institute of Bioinformatics (INB). Scientific Director of Bioinformatics Barcelona (BIB). President of the European Federation for Medicinal Chemistry (EFMC) from January 2003 to December 2005. Vice-rector for Scientific Policy of the UPF from January 2004 to March 2009. Member of the Scientific Committee of Innovative Medicines Initiative until 2013.
Computational approaches in drug discovery and development with a particular focus on the prediction of potential adverse drug reactions.
Integrative knowledge management and exploitation in biomedicine, including multi-level and multi-scale modelling and simulation.